Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children.

ABSTRACT:

Background

Acute gastroenteritis develops in millions of children in the United States every year, and treatment with probiotics is common. However, data to support the use of probiotics in this population are limited.

Methods

We conducted a prospective, randomized, double-blind trial involving children 3 months to 4 years of age with acute gastroenteritis who presented to one of 10 U.S. pediatric emergency departments. Participants received a 5-day course of Lactobacillus rhamnosus GG at a dose of 1×10¹⁰ colony-forming units twice daily or matching placebo. Follow-up surveys were conducted daily for 5 days and again 14 days after enrollment and 1 month after enrollment. The primary outcome was moderate-to-severe gastroenteritis, which was defined as an illness ep

SUBMITTER: Schnadower D 

PROVIDER: S-EPMC6358014 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature